In particular, 89% of Puerto Rican HPS patients, who are mostly HPS-1 or HPS-3 (forming the same BLOC-2 complex with HPS5 and HPS6 proteins), were reported as poor responses to DDAVP treatment (Cordova et al., 2005). The gene discussed is HPS1; the disease is Hermansky-Pudlak syndrome.